25th Korean College of Helicobacter and Upper Gastrointestinal Research Annual Scientific Meeting and 14th Japan-Korea Joint Symposium on Helicobacter Research
International Symposium III (Acid-related Diseases in Asia) 6TGCVOGPV 5VTCVGI[ HQT EJTQPKE ICUVTKVKU KP #UKC
/CTEGNNWU 5KOCFKDTCVC Division of Gastroenterology Department of Internal Medicine Cipto Mangunkusumo National General Hospital Jakarta Jl. Indonesia
^FXUULFXOXP YLWDH`
2012 Fellow of the American Society of Gastrointestinal Endoscopy. 2010 Fellow of the Indonesian Internal Medicine 2009 Fellow of the American College of Gastroenterology 2002 PhD, Universiteit van Amsterdam, Netherland 1998 Consultant of Gastroentero-hepatology 1991 Internal Medicine, University of Indonesia, Jakarta 1981 Medical Doctor, University of Indonesia, Jakarta 2009 Asia Pacific Basic Hands-on EUS Course, National University Health System & Khoo Tack P Advanced Surgery Training Centre, Singapore 2009 ASGE Postgraduate Course- Integrating Endoscopic Advances into Clinical Practice, ASGE-ACG, California 2009 Annual Postgraduate Course 2009, The American College of Gastroenterology (ACG), California 2008 Hands on Workshop on Endoscopic Ultrasonography (EUS), Singapore 2008 Preconference Workshop on Medical Education, Website Instructional Design and Clinical Assessment, Asian Pacific Medical Education Conference (APMEC) 2008, Singapore 2007 American College Gastroenterology (ACG) Regional Course on Gastroenterology, Chicago 2007 Course on Writing, Preconference Workshop, APMEC 2007, Singapore 2006 Course on Capsule Endoscopy. Chicago USA 2003 Asia Pacific Postgraduate Course on Gastrointestinal Motility (APPGM), Korea 1996 Advanced Therapeutic Endoscopy, ERCP, Hamburg 1995 Early Diagnosis & Management of Gastrointestinal Tumor JICA, Japan Etc.
56 0DUFHOOXV 6LPDGLEUDWD 7UHDWPHQW 6WUDWHJ\ IRU FKURQLF JDVWULWLV LQ $VLD
^DEVWUDFW`
Chronic gastritis is frequent in daily practice in Asia. Chronic gastritis can frequently prog- ress through the precancerous gastric lesions intestinal metaplasia and gastric intraepithelial neoplasia, resulting in gastric cancer. Major Cause of chronic gastritis and the subsequent de- velopment of stomach cancers is Helicobacter pylori infections. Other causes of chronic gastritis are NSAID consumption, alcohol, stress, autoimmune etc. The treatment strategy for chronic gastritis can be divided into non-pharmacologic and pharmacologic. The non-pharmacologic treatment include s tomach diet, stress therapy and education about the disease. The phar- macologic treatment incluce H2 Receptor Antagonis, proton pump inhibitoir, K channel blocker, cytoprotector, anti anxiety/anti depressants and Antibiotics for Helicobacter pylori infection. The H2 receptor antagonists are cimetidine, ranitidine, famotidine. The Proton pump Inhibitors include omeprazole, lansoprazole, pantoprazole, rabeprazole, esomeprazole, tenatoprazole. Antibiotics for Helicobacter pylori infections are : Amoxycillin, Clarithromycin, Metronidazole, levofloxacine etc. The cytoprotectors divided into rebamipide, sucralfate, tephrenone. Rebamipide inhibits the activation of white blood cells, scavenges free radicals, and increases gastric mucus secretion and prostaglandin levels. Simadibrata M et.al. in their study found that rebamipide significantly reduced the extend of symptoms associated with chronic gastritis. The improvement in symptoms was associated with the decreased of endo- scopic score and the mean gastric mucosal malondialdehyde(MDA) significantly. Xan X et.al.from their study found that Treatment with rebamipide 0.1 g three times per day for 26 weeks significantly reduced clinical symptom and gastric mucosal lesion scores as well as in- flammation, intestinal metaplasia, and low-grade intraepithelial neoplasia. Rebamipide is an efficacious medication for mucosa recovery of chronic gastritis patients.
57